Bayer wins EU endorsement for Xarelto in lung embolism
FRANKFURT (Reuters) - German drugmaker Bayer said its Xarelto blood-thinning pill was recommended for approval by the European drugs regulator for the treatment of dangerous blood clots of the lung, a condition known as pulmonary embolism.
Bayer also won an endorsement from watchdog European Medicines Agency (EMA) for the pill's use in preventing recurrent deep vein thrombosis - another form of blood clotting - Bayer said in a statement on Friday.
EMA's guidance is usually followed by the EU Commission for its decisions on drug approvals.
(Reporting by Ludwig Burger)
- Israeli air strike kills three Hamas commanders in Gaza |
- U.S. military failed in rescue attempt for journalist Foley |
- Obama condemns killing of reporter, U.S. hits militants in Iraq |
- Calm largely holds in Missouri after grand jury opens shooting investigation |
- Russia extends scrutiny of McDonald's restaurants |
Robert Blendon of the Harvard School of Public Health says the Affordable Care Act's unpopularity in 12 key states will keep it a central issue in the 2014 elections. Video